FDA panel backs low-dose Pfizer vaccines for children
By Staff Reports / October 26, 2021A Food and Drug Administration (FDA) panel voted unanimously, with one abstention, Oct. 26 to endorse kid-size doses of the Pfizer COVID-19 vaccine for children 5- to 11-years-old.